Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Absent Mandatory Listing, US FDA Acknowledges Its Supplement Directory Isn’t Comprehensive

Mar 07 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US Consumer Health Industry In 2023: Mandatory Listing Has Supplement Sector’s Attention

Jan 30 2023

US VMS Industry Makes Lame Duck Session List, Checks It Twice For MPL Language

Dec 06 2022

FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements

Apr 17 2019

Additional Topics

International United States Dietary Supplements FDA Regulation Advertising, Marketing & Sales Commercial Compliance Consumer Enforcement Ingredients Manufacturing Legislation Policy Politics Retail

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.